LogicBio Therapeutics, Inc. Liabilities Assumed
LogicBio Therapeutics, Inc. reported Liabilities Assumed of $133.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2021-11-15
- LogicBio Therapeutics, Inc. liabilities assumed for the quarter ending 2018-12-31 was -$1.07M.
- LogicBio Therapeutics, Inc. liabilities assumed for fiscal 2018 was $32.00K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2020-09-30 | $133.00K 10-Q · filed 2021-11-15 | |||
| 2019-06-30 | $39.00K 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $32.00K 10-K · filed 2020-03-16 | ||
| 2018-09-30 | $1.11M 10-Q · filed 2019-11-12 |